| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004271711 |
| P356 | DOI | 10.1007/S10549-010-0840-0 |
| P932 | PMC publication ID | 2968705 |
| P698 | PubMed publication ID | 20309628 |
| P5875 | ResearchGate publication ID | 42390602 |
| P50 | author | Christine Ambrosone | Q52931455 |
| Ji-Yeob Choi | Q91146983 | ||
| P2093 | author name string | Warren Davis | |
| Gabriel N Hortobagyi | |||
| C Kent Osborne | |||
| Daniel F Hayes | |||
| Hua Zhao | |||
| Alan P Lyss | |||
| Kathy S Albain | |||
| William E Barlow | |||
| I-Tien Yeh | |||
| Robert B Livingston | |||
| Silvana Martino | |||
| Song Yao | |||
| Peter M Ravdin | |||
| James M Rae | |||
| Laura F Hutchins | |||
| Martin D Abeloff | |||
| P2860 | cites work | Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer. | Q46961622 |
| Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's di | Q48060154 | ||
| Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. | Q54039560 | ||
| Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria | Q67993403 | ||
| Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer | Q33265408 | ||
| Genetic predictors of long-term toxicities after radiation therapy for breast cancer | Q33306558 | ||
| Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897 | Q33561166 | ||
| Mitochondrion as a novel target of anticancer chemotherapy | Q33958275 | ||
| Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer | Q34162335 | ||
| The role of genetic variability in drug metabolism pathways in breast cancer prognosis | Q36497088 | ||
| A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide | Q37229749 | ||
| Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial | Q37351248 | ||
| Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples | Q38451385 | ||
| The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. | Q40428545 | ||
| A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy | Q40887240 | ||
| Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. | Q44212824 | ||
| The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria | Q44346876 | ||
| Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase | Q44683532 | ||
| Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. | Q45261353 | ||
| REporting recommendations for tumor MARKer prognostic studies (REMARK). | Q46099462 | ||
| Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. | Q46341971 | ||
| Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer | Q46395715 | ||
| Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol I | Q46809317 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 433-439 | |
| P577 | publication date | 2010-03-23 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer | |
| P478 | volume | 124 |
| Q35879741 | Actionable pharmacogenetic markers for prediction and prognosis in breast cancer. |
| Q44221204 | Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas |
| Q46092058 | Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer |
| Q37388019 | Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma |
| Q34682560 | Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer |
| Q36538460 | Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patients. |
| Q36535678 | Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research |
| Q37538755 | Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis |
| Q35536092 | Manganese superoxide dismutase: guardian of the powerhouse |
| Q42706074 | MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen |
| Q34783589 | Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy |
| Q51297212 | Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients. |
| Q35440258 | SOD2 rs4880 CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q42376302 | There is no relationship between SOD2 Val-16Ala polymorphism and breast cancer risk or survival |
| Q94464134 | Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy |
Search more.